Search Results

Most teams don’t stall because the science is weak. They stall because the data becomes a mess. The Hidden Cost of Good Science Without Systems I’ve seen this pattern again and again—across academia Strong science. Promising data. But no systems to turn it into momentum. drgpcr/yamina-corner Or explore how we can work together: 👉 Yamina.org 🔑 Key Takeaways ✅ Even strong science

The difference between surviving and failing in biotech is rarely science. Science evolves in parallel with regulatory funding pressure and team growth.   Not because the science stops working, but because the organization stops knowing what matters most right Strategy creates a shared filter that connects science execution and business reality. ✅ At its core, Without it, even strong science slowly loses direction. 👉 Understanding why biotech startups fail  is

It began in Bari, Italy, with a love for science nurtured by her father and fueled by childhood cartoons without the delays and frustrations that often plague probe development. 👉 Learn more about Celtarys’ science-driven

GPCR, it was with a simple goal: to connect people who shared a passion for GPCR science and discovery These resources continue to bring the latest in GPCR science and industry updates to thousands across GPCR Foundry  — our R&D and biotech hub designed to bridge GPCR science with execution. The Dr. GPCR Foundry: Science Meets Execution The Foundry is where we bring together biotech innovators, Venture the podcast and blog to our Premium ecosystem and Foundry initiatives, our mission is to advance GPCR science

Scroll down for the science, the strategy, and the sweet stuff 🍬 Dr. Wear Your Science – Dr. GPCR merch is here! Show off your receptor pride and support the mission.

signaling, and inflammation-linked GPCRs — and curated roles in computational and membrane protein science scientists Influence   the curriculum with your topic suggestions Weekly new releases  to stay ahead of the science new episodes will drop bi-weekly on Wednesday mornings  — giving you mid-week insights that connect science It’s about how Revvity turns deep science into tools that endure. Read the full story➤ Why Dr.

Scientists, investors, and CRO professionals fly in from around the world, while Boston’s own vibrant life sciences Our mission is simple: bridge science and industry  by connecting researchers, biotech, CROs, and pharma chance to be part of the conversations that will ripple far beyond Boston. ✨ GPCR Happy Hour: Where science

And it’s a reminder that the way we do science today wasn’t inevitable — it was engineered, learned, Luck, and the Lab The episode isn’t just about technology — it’s also about how careers are shaped in science Technology accelerates science, but people direct it.

Kenakin walks you through the science, the data, and the practical methods for making it happen.   Unlock “Intracellular Drugs” Now Only in Terry’s Corner   Why Terry’s Corner In a world where GPCR science Stay ahead with The Kenakin Brief  — a concise, science‑first email update with the latest insights in

If you’re building tools or careers in GPCR science, this is your playbook. Product development isn’t just about science. you’re launching a tool, starting a biotech, or running an academic lab—your mindset, not just your science

insights from molecular dynamics, biased signaling, and allosteric modulation, this session lays bare the science

Uniqueness of Pharmacology in Drug Discovery,” Terry Kenakin explains why pharmacology isn’t a clean-cut science—it

GPCR , the global nonprofit platform dedicated to advancing GPCR science through education, community and innovate in the world of G protein-coupled receptors . 🔗 About Revvity Revvity  is a global life sciences

foundational-level  lesson, Terry unpacks the real-life process behind discovering new drugs, breaking down the science

For instance, Heydenreich et al. (2023) developed a data science framework that combined mutagenesis Deep mutational scanning: a new style of protein science. Nature Methods , 11 (8), 801-807. Science , 382 (6677), eadh1859. Kosar, M., Sarott, R. C., Sykes, D. A., Viray, A. E., Vitale, R. ACS Central Science , 10 (5), 956-968. Nguyen, A. T., Baltos, J.-A., Thomas, T., Nguyen, T.

challenges: missed opportunities, misaligned systems, and promising programs stalling despite strong science Here's how I bring a fresh perspective: Biology-First, Data-Driven Strategy:  I help you focus on the science

Sometimes, science rewards the bold. _________________ Keyword Cloud: GPCR online course, early-career

Terry Kenakin to elevate your science and sharpen your calls. It’s built for the GPCR community—by people who live the science—so you spend less time sifting and more masterful teacher and communicator." — DrGPCR University Attendee Everything you need to master GPCR science

Terry Kenakin to elevate your science and sharpen your decisions. Career opportunities:  Research Assistant; Postdoctoral Associate; Senior Scientist, Data Science—curated to turn ambiguous signals into confident, defensible decisions—and join a community designed to move science

Watch Episode 172 The Bigger Picture: GPCR Science Meets Public Health At its core, Catherine Demery’ In other words, this is GPCR science with immediate, life-or-death consequences. The question now is whether science and public health can keep up.”

👉 Join Terry’s Corner, your essential launchpad into the world of therapeutic science Unlock "The History

Watch Episode 168 Success in science is rarely linear.

Watch Episode 169 Leadership in science isn't just about results, it's about people.

decisions ➤ Yamina’s Corner - The Hidden Cost of Busy A GPCR program can collapse—not because of bad science Each week, you gain curated intelligence across science, careers, and strategy: Deep-dive expert lectures

delivers trusted, razor-sharp insight to help drug discovery professionals like you stay ahead of the science Terry’s Pharmacology Corner  is your trusted, expert-led guide through the evolving landscape of GPCR science

As a lab technician at Johns Hopkins, he was fascinated by science but also grounded in real-life responsibilities

built a global network of researchers, biotech leaders, and pharma innovators who believe that GPCR science biotech leaders, CRO professionals, and investors from around the globe meet Boston’s vibrant life sciences

His work highlights how foundational GPCR science can drive therapeutic innovation.

Why this matters: Secure your voice in the next chapter of GPCR science.   Target ➤ What our community is saying “I enjoy the breadth of questioning that goes beyond just the science

GPCR Podcast on Self-Learning, Collaboration, and Delegation in Science with Dr. 7, 2024 | Chemotactic Cytokines June 4, 2024 | Live Webinar ‘It All Starts With a Protein – Protein Sciences Receptor Pharmacology PostDoctoral Scientist Senior Research Associate/Associate Scientist, Protein Science